Neuronetics, Inc. Files 8-K for Regulation FD Disclosure
Ticker: STIM · Form: 8-K · Filed: Mar 5, 2024 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
Neuronetics dropped an 8-K, likely a Reg FD disclosure. Watch for updates.
AI Summary
On March 5, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating a public disclosure of material information. No specific financial figures or new business developments were detailed in the provided excerpt.
Why It Matters
This filing signals that Neuronetics has made a public disclosure of information that could be material to investors, requiring transparency under Regulation FD.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for a Regulation FD disclosure, which typically doesn't involve immediate financial risk or significant operational changes.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- March 5, 2024 (date) — Date of Report
- Regulation FD (regulation) — Disclosure type
FAQ
What specific information was disclosed under Regulation FD?
The provided excerpt does not specify the content of the Regulation FD disclosure; it only indicates that such a disclosure was made on March 5, 2024.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure made by Neuronetics, Inc. on March 5, 2024.
When was Neuronetics, Inc. incorporated?
Neuronetics, Inc. was incorporated in Delaware.
What is Neuronetics, Inc.'s principal executive office address?
The principal executive offices of Neuronetics, Inc. are located at 3222 Phoenixville Pike, Malvern, PA 19355.
What is the SIC code for Neuronetics, Inc.?
The Standard Industrial Classification (SIC) code for Neuronetics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 376 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-03-05 07:30:31
Key Financial Figures
- $0.01 — nge on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M
Filing Documents
- stim-20240305x8k.htm (8-K) — 30KB
- 0001558370-24-002410.txt ( ) — 146KB
- stim-20240305.xsd (EX-101.SCH) — 3KB
- stim-20240305_lab.xml (EX-101.LAB) — 16KB
- stim-20240305_pre.xml (EX-101.PRE) — 10KB
- stim-20240305x8k_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On March 5, 2024, Neuronetics, Inc. posted its March 2024 investor presentation and supplemental financial and operating information to its website at http://ir.neuronetics.com . SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEURONETICS, INC. (Registrant) Date: March 5, 2024 By: /s/ Stephen Furlong Name: Stephen Furlong Title: EVP, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)